Abstract
Long-chain polyunsaturated fatty acids (LCPUFA) including eicosapentaenoic acid (EPA, 20:5n-3) and docosahexaenoic acid (DHA, 22:6n-3) have become important natural health products with numerous proven benefits related to brain function and cardiovascular health. Not only are omega-3 fatty acids available in a plethora of dietary supplements, but they are also increasingly being incorporated as triglycerides into conventional foods, including bread, milk, yoghurt and confectionaries. Recently, transgenic oil seed crops and livestock have been developed that enhance omega-3 fatty acid content. This diverse array of matrices presents a difficult analytical challenge and is compounded further by samples generated through clinical research. Stable isotope 13C-labelled LCPUFA standards offer many advantages as research tools because they may be distinguished from their naturally abundant counterparts by mass spectrometry and directly incorporated as internal standards into analytical procedures. Further, 13C-labelled LCPUFAs are safe to use as metabolic tracers to study uptake and metabolism in humans. Currently, 13C-labelled LCPUFAs are expensive, available in limited supply and not in triglyceride form. To resolve these issues, marine heterotrophic microorganisms are being isolated and screened for LCPUFA production with a view to the efficient biosynthetic production of U-13C-labelled fatty acids using U-13C glucose as a carbon source. Of 37 isolates obtained, most were thraustochytrids, and either DHA or omega-6 docosapentaenoic acid (22:5n-6) were produced as the major LCPUFA. The marine protist Hyalochlorella marina was identified as a novel source of EPA and omega-3 docosapentaenoic acid (22:5n-3). As proof of principle, gram-level production of 13C-labelled DHA has been achieved with high chemical purity ( >99%) and high 13C incorporation levels (>90%), as confirmed by NMR and MS analyses. Finally, U-13C-DHA was enzymatically re-esterified to glycerol to yield a 13C-labelled tridocosahexaenoin.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Dyerberg J, Bang HO, Hjorne N (1975) Am J Clin Nut 28:958–966
Simopoulos AP, Leaf A, Salem N Jr (1999) Ann Nutr Metab 43:127–130
Marchioli R, Barzi F, Bomba E, Chieffo C, Di Gregorio D, Di Mascio R, Franzosi MG, Geraci E, Levantesi G, Maggioni AP, Mantini L, Marfisi RM, Mastrogiuseppe G, Mininni N, Nicolosi GL, Santini M, Schweiger C, Tavazzi L, Tognoni G, Tucci C, Valagussa F (2002) Circulation 105:1897–1903
Iso H, Kobayashi M, Ishihara J, Sasaki S, Okada K, Kita Y, Kokubo Y, Tsugane S (2006) Circulation 113:195–202
Cunnane SC (2001) Lipids 36:975–979
Holub DJ, Holub BJ (2004) Mol Cell Biochem 263:217–225
Kris-Etherton PM, Harris WS, Appel LJ (2002) Circulation 106:2747–2757
Ward OP, Singh A (2005) Proc Biochem 40:3627–3652
Wu G, Truksa M, Datla N, Vrinten P, Bauer J, Zank T, Cirpus P, Heinz E, Qiu X (2005) Nat Biotechnol 23:1013–1017
Lai L, Kang JX, Li R, Wang J, Witt WT, Yong HY, Hao Y, Wax DM, Murphy CN, Rieke A, Samuel M, Linville ML, Korte SW, Evans RW, Starzl TE, Prather RS, Dai Y (2006) Nat Biotechnol 24:435–436
Whiting TC, Liu RH, Chang W-T, Bodapati, MR (2001) J Anal Toxicol 25:179–189
Ackman RG, Sipos JC, Jangaard PM (1967) Lipids 2:251–257
Christie WW (1993) In: Christie WW (ed) Advances in lipid methodology 2. Oily, Dundee, UK
Apt KE, Behrens, PW (1999) J Phycol 35:215–226
Acién Fernández FG, Brindley Alías C, García-Malea Lopez MC, Fernández Sevilla JM, Ibáñez González MJ, Núñez Gómez R, Molina Grima E (2003) Biomol Eng 20:149–162
Watanabe K, Nakahara T, Yokochi T, Mohara S, Yazawa K (2000) J Jap Oil Chem Soc 49:1437–1441
Chen G-Q, Chen F (2006) Biotech Lett 28:607–616
Burja AM, Radianingtyas H, Windust A, Barrow CJ (2006) Appl Microbiol Biotechnol 72:1161–1169
McLachlan JL (1973) In: Stein JR (ed) Handbook of phycological methods. Cambridge University Press, New York
Michaud AL, Diau G-Y, Abril R, Brenna JT (2002) Anal Biochem 307:348–360
Biemann K (1962) Mass spectrometry: organic and chemical applications. McGraw-Hill, New York
Bowles RD, Hunt AE, Bremer GB, Duchars MG, Eaton RA (1999) J Biotechnol 70:193–202
Lewis TE, Nichols PD, McMeekin TA (1999) Mar Biotechnol 1:580–587
Poyton RO (1970) J Gen Micro 62:171–188
Bénistant C, Achard F, Ben Slama S, Lagarde M (1996) Prostaglandins Leuk Essent Fatty Acids 55:287–292
Kanayasu-Toyoda T, Morita I, Murota S (1996) Prostag Leukotr Ess 54:319–325
Tsuji M, Murota S, Morita I (2003) Prostag Leukotr Ess 68:337–342
Hamam F, Shahidi F (2006) Prostag Leukotr Ess 54:4390–4396
Abuzaytoun R, Shahidi F (2006) J Agric Food Chem 54:8253–8260
Aursand M, Mabon F, Martin GJ (1997) Magn Reson Chem 35:S91–S100
Acknowledgements
The authors thank NIH (ODS) for financial support to Phuong Mai Le and Gilles Robertson for assistance with the acquisition of NMR spectra.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Le, P.M., Fraser, C., Gardner, G. et al. Biosynthetic production of universally 13C-labelled polyunsaturated fatty acids as reference materials for natural health product research. Anal Bioanal Chem 389, 241–249 (2007). https://doi.org/10.1007/s00216-007-1305-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00216-007-1305-0